Iconovo AB (publ)
ICO
Rank in Stocks
#28547
Based in Lund, Sweden, Iconovo AB (publ) focuses on the creation and licensing... Based in Lund, Sweden, Iconovo AB (publ) focuses on the creation and licensing of advanced inhalation delivery systems. Their product portfolio encompasses a variety of dry powder inhalers, such as the versatile multi-dose ICOres, the capsule-driven ICOcap, the single-use disposable ICOone, and the pre-metered ICOpre. Beyond these standard devices, the company also designs custom inhalation solutions, primarily catering to generic pharmaceutical firms. Iconovo is involved in significant collaborative ventures, including a project with Immune System Regulation AB to develop an inhaled COVID-19 vaccine using their ICOone inhaler, and a partnership with Respiratorius AB (publ) to formulate an inhalation treatment for COPD. The company was established in 2013.
Share Price
$0.11171862
Last synced: 2026-11-09
Market Cap
$10.74M
Change (1 day)
5.24%
Change (1 year)
-39.27%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Iconovo AB (publ) (ICO)
Category
Healthcare
Operating Margin for Iconovo AB (publ) (ICO)
Operating Margin as of November 2026 TTM: -1,531.75%
According to Iconovo AB (publ)'s latest financial reports, its current operating margin (TTM) is -1,531.75%. At the end of 2025 the company had an operating margin of -3,959.55%.
Operating Margin history for Iconovo AB (publ) from 2015 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1,531.75% | -61.32% |
| 2025 | -3,959.55% | 182.83% |
| 2024 | -1,400.00% | 116.48% |
| 2023 | -646.72% | 128.90% |
| 2022 | -282.53% | 64.30% |
| 2021 | -171.96% | 85.52% |
| 2020 | -92.69% | -7.61% |
| 2019 | -100.32% | 105.28% |
| 2018 | -48.87% | -457.76% |
| 2017 | 13.66% | -45.53% |
| 2016 | 25.08% | -103.54% |
| 2015 | -707.54% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.01% |
US
|
|
| 18.08% | -100.01% |
IE
|
|
| 21.25% | -100.01% |
US
|
|
| 21.05% | -100.01% |
US
|
|
| 28.09% | -100.02% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Iconovo AB (publ)'s operating margin
What is Iconovo AB (publ)'s operating margin?
Iconovo AB (publ)'s operating margin is -1,531.75%, as of Nov 2026.
What was Iconovo AB (publ)'s operating margin in 2025?
In 2025, Iconovo AB (publ)'s operating margin was -3,959.55%, compared with -1,400.00% in 2024.
How has Iconovo AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Iconovo AB (publ)'s operating margin was highest in 2020 (-92.69%) and lowest in 2025 (-3,959.55%).
How does Iconovo AB (publ)'s operating margin compare with similar companies?
Iconovo AB (publ)'s operating margin (-1,531.75%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.